TARS
Tarsus Pharmaceuticals, Inc.
+0.47 (+0.61%)78.11USD119K成交股數3.4B市值–本益比(近四季)5.7股價營收比+69.4%營收年增(近四季)2026-11-04下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 11 · 4.2M · 3 |
| 其中 10b5-1 計畫賣出 | 11 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 6.7M |
| 近 180 天 淨額 | −6.7M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-04 | 09-09 | Neervannan Seshadri | Chief Operating Officer | S 公開市場賣出(10b5-1) | 4.6K | 85.00 | 388K | 78.5K | SEC |
| 2026-09-04 | 09-09 | Lin Elizabeth Yeu | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.4K | 90.00 | 485K | 2.5K | SEC |
| 2026-09-04 | 09-09 | Lin Elizabeth Yeu | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.6K | 90.00 | 143K | 1.6K | SEC |
| 2026-09-04 | 09-09 | Lin Elizabeth Yeu | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.4K | 85.00 | 458K | 7.9K | SEC |
| 2026-09-04 | 09-09 | Azamian Bobak R. | President/CEO and Board Chair | S 公開市場賣出(10b5-1) | 2.9K | 91.27 | 265K | 828K | SEC |
| 2026-09-04 | 09-09 | Azamian Bobak R. | President/CEO and Board Chair | S 公開市場賣出(10b5-1) | 7.1K | 90.27 | 641K | 831K | SEC |
| 2026-09-04 | 09-09 | Lin Elizabeth Yeu | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.6K | 85.00 | 135K | 3.2K | SEC |
| 2026-09-02 | 09-03 | Lin Elizabeth Yeu | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.4K | 80.00 | 431K | 13.3K | SEC |
| 2026-09-02 | 09-03 | Lin Elizabeth Yeu | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.6K | 80.00 | 127K | 4.8K | SEC |
| 2026-09-02 | 09-03 | Azamian Bobak R. | President/CEO and Board Chair | S 公開市場賣出(10b5-1) | 10.0K | 80.06 | 801K | 838K | SEC |
| 2026-09-01 | 09-03 | Lin Elizabeth Yeu | Chief Medical Officer | S 公開市場賣出(10b5-1) | 4.6K | 73.86 | 340K | 18.7K | SEC |
| 2026-06-17 | 06-22 | Azamian Bobak R. | President/CEO and Board Chair | S 公開市場賣出(10b5-1) | 4.6K | 61.24 | 281K | 853K | SEC |
| 2026-06-17 | 06-22 | Azamian Bobak R. | President/CEO and Board Chair | S 公開市場賣出(10b5-1) | 5.4K | 61.81 | 335K | 848K | SEC |
| 2026-06-16 | 06-17 | Farrow Jeffrey S | See Remarks | S 公開市場賣出 | 14.4K | 60.95 | 877K | 56.8K | SEC |
| 2026-06-15 | 06-17 | LINK WILLIAM J PHD | Director | S 公開市場賣出(10b5-1) | 1.9K | 62.94 | 121K | 107K | SEC |
| 2026-06-15 | 06-17 | Goodrich Katherine | Director | S 公開市場賣出(10b5-1) | 3.0K | 62.08 | 183K | 2.2K | SEC |
| 2026-06-15 | 06-17 | LINK WILLIAM J PHD | Director | S 公開市場賣出(10b5-1) | 10.6K | 61.97 | 655K | 109K | SEC |
| 2026-06-15 | 06-17 | Farrow Jeffrey S | See Remarks | M 選擇權執行 | 27.9K | – | – | 71.2K | SEC |
| 2026-06-12 | 06-16 | Goodrich Katherine | Director | M 選擇權執行 | 3.0K | – | – | 5.2K | SEC |
| 2026-06-12 | 06-16 | YARNO WENDY L | Director | M 選擇權執行 | 3.0K | – | – | 16.7K | SEC |
| 2026-06-12 | 06-16 | Morrison Scott W | Director | M 選擇權執行 | 3.0K | – | – | 7.6K | SEC |
| 2026-06-12 | 06-16 | Goldberg Andrew D. | Director | M 選擇權執行 | 3.0K | – | – | 19.7K | SEC |
| 2026-06-12 | 06-16 | CHAUDHURI BHASKAR | Director | M 選擇權執行 | 3.0K | – | – | 11.7K | SEC |
| 2026-06-12 | 06-16 | LINK WILLIAM J PHD | Director | M 選擇權執行 | 3.0K | – | – | 119K | SEC |
| 2026-04-24 | 04-28 | PYOTT DAVID E I | Director | M 選擇權執行 | 1.4K | – | – | 1.4K | SEC |
| 2026-03-20 | 03-24 | Neervannan Seshadri | Chief Operating Officer | S 公開市場賣出(10b5-1) | 3.0K | 66.75 | 200K | 82.8K | SEC |
| 2026-03-19 | 03-19 | Farrow Jeffrey S | See Remarks | S 公開市場賣出 | 2.2K | 67.00 | 146K | 43.3K | SEC |
| 2026-03-19 | 03-19 | Wahl Bryan | General Counsel | S 公開市場賣出 | 4.2K | 67.00 | 283K | 64.0K | SEC |
| 2026-03-19 | 03-19 | Whitfield Dianne C. | Chief Human Resources Officer | S 公開市場賣出 | 4.2K | 67.00 | 280K | 35.0K | SEC |
| 2026-03-19 | 03-19 | Azamian Bobak R. | President/CEO and Board Chair | S 公開市場賣出 | 12.0K | 67.00 | 802K | 33.4K | SEC |
| 2026-03-19 | 03-19 | Lin Elizabeth Yeu | Chief Medical Officer | S 公開市場賣出 | 390 | 67.00 | 26K | 23.3K | SEC |
| 2026-03-19 | 03-19 | Neervannan Seshadri | Chief Operating Officer | S 公開市場賣出 | 4.6K | 67.00 | 307K | 85.8K | SEC |
| 2026-03-19 | 03-19 | Mottiwala Aziz | Chief Commercial Officer | S 公開市場賣出 | 4.4K | 67.00 | 297K | 61.5K | SEC |
| 2026-03-18 | 03-19 | Mottiwala Aziz | Chief Commercial Officer | S 公開市場賣出 | 4.3K | 68.71 | 298K | 65.9K | SEC |
| 2026-03-18 | 03-19 | Farrow Jeffrey S | See Remarks | S 公開市場賣出 | 2.1K | 68.71 | 147K | 45.5K | SEC |
| 2026-03-18 | 03-19 | Lin Elizabeth Yeu | Chief Medical Officer | S 公開市場賣出 | 379 | 68.71 | 26K | 23.7K | SEC |
| 2026-03-18 | 03-19 | Wahl Bryan | General Counsel | S 公開市場賣出 | 4.1K | 68.71 | 283K | 68.2K | SEC |
| 2026-03-18 | 03-19 | Whitfield Dianne C. | Chief Human Resources Officer | S 公開市場賣出 | 4.1K | 68.71 | 280K | 39.2K | SEC |
| 2026-03-18 | 03-19 | Neervannan Seshadri | Chief Operating Officer | S 公開市場賣出 | 3.6K | 68.71 | 248K | 90.4K | SEC |
| 2026-03-18 | 03-19 | Azamian Bobak R. | President/CEO and Board Chair | S 公開市場賣出 | 11.7K | 68.71 | 802K | 45.4K | SEC |
| 2026-03-17 | 03-19 | Mottiwala Aziz | Chief Commercial Officer | S 公開市場賣出 | 4.3K | 69.42 | 298K | 70.3K | SEC |
| 2026-03-17 | 03-19 | Farrow Jeffrey S | See Remarks | S 公開市場賣出 | 2.1K | 69.42 | 147K | 47.6K | SEC |
| 2026-03-17 | 03-19 | Lin Elizabeth Yeu | Chief Medical Officer | S 公開市場賣出 | 375 | 69.42 | 26K | 24.1K | SEC |
| 2026-03-17 | 03-19 | Wahl Bryan | General Counsel | S 公開市場賣出 | 4.1K | 69.42 | 284K | 72.3K | SEC |
| 2026-03-17 | 03-19 | Whitfield Dianne C. | Chief Human Resources Officer | S 公開市場賣出 | 4.0K | 69.42 | 280K | 43.3K | SEC |
| 2026-03-17 | 03-19 | Azamian Bobak R. | President/CEO and Board Chair | S 公開市場賣出 | 11.0K | 69.42 | 762K | 57.1K | SEC |
| 2026-03-17 | 03-19 | Neervannan Seshadri | Chief Operating Officer | S 公開市場賣出 | 3.1K | 69.42 | 217K | 94.0K | SEC |
| 2026-03-16 | 03-18 | LINK WILLIAM J PHD | Director | S 公開市場賣出(10b5-1) | 3.6K | 68.09 | 247K | 125K | SEC |
| 2026-03-16 | 03-18 | LINK WILLIAM J PHD | Director | S 公開市場賣出(10b5-1) | 8.4K | 69.03 | 578K | 117K | SEC |
| 2026-03-16 | 03-18 | LINK WILLIAM J PHD | Director | S 公開市場賣出(10b5-1) | 493 | 69.75 | 34K | 116K | SEC |
| 2026-03-15 | 03-17 | Farrow Jeffrey S | See Remarks | M 選擇權執行 | 13.0K | – | – | 49.7K | SEC |
| 2026-03-15 | 03-17 | Lin Elizabeth Yeu | Chief Medical Officer | M 選擇權執行 | 2.5K | – | – | 24.5K | SEC |
| 2026-03-15 | 03-17 | Wahl Bryan | General Counsel | M 選擇權執行 | 24.2K | – | – | 76.4K | SEC |
| 2026-03-15 | 03-17 | Mottiwala Aziz | Chief Commercial Officer | M 選擇權執行 | 26.5K | – | – | 74.5K | SEC |
| 2026-03-15 | 03-17 | Whitfield Dianne C. | Chief Human Resources Officer | M 選擇權執行 | 23.9K | – | – | 47.3K | SEC |
| 2026-03-15 | 03-17 | Azamian Bobak R. | President/CEO and Board Chair | M 選擇權執行 | 66.3K | – | – | 68.0K | SEC |
| 2026-03-15 | 03-17 | Neervannan Seshadri | Chief Operating Officer | M 選擇權執行 | 26.3K | – | – | 97.1K | SEC |
| 2026-03-04 | 03-05 | Neervannan Seshadri | Chief Operating Officer | S 公開市場賣出(10b5-1) | 8.4K | 76.67 | 641K | 70.8K | SEC |
| 2026-01-02 | 01-06 | Whitfield Dianne C. | Chief Human Resources Officer | S 公開市場賣出(10b5-1) | 893 | 82.93 | 74K | 23.4K | SEC |
| 2026-01-02 | 01-06 | Whitfield Dianne C. | Chief Human Resources Officer | S 公開市場賣出(10b5-1) | 835 | 81.90 | 68K | 24.3K | SEC |
| 2026-01-02 | 01-06 | Whitfield Dianne C. | Chief Human Resources Officer | S 公開市場賣出(10b5-1) | 8.1K | 80.71 | 656K | 25.1K | SEC |
| 2026-01-02 | 01-06 | Whitfield Dianne C. | Chief Human Resources Officer | S 公開市場賣出(10b5-1) | 5.7K | 80.09 | 458K | 33.2K | SEC |
| 2025-12-24 | 12-30 | Azamian Bobak R. | President/CEO and Board Chair | S 公開市場賣出(10b5-1) | 5.4K | 82.41 | 449K | 859K | SEC |
| 2025-12-24 | 12-30 | Azamian Bobak R. | President/CEO and Board Chair | S 公開市場賣出(10b5-1) | 557 | 83.54 | 47K | 858K | SEC |
| 2025-12-16 | 12-18 | Whitfield Dianne C. | Chief Human Resources Officer | S 公開市場賣出(10b5-1) | 7.4K | 80.10 | 592K | 39.0K | SEC |
| 2025-12-16 | 12-18 | Neervannan Seshadri | Chief Operating Officer | G 贈與 | 475 | – | – | 475 | SEC |
| 2025-12-16 | 12-18 | Neervannan Seshadri | Chief Operating Officer | G 贈與 | 950 | – | – | 79.2K | SEC |
| 2025-12-16 | 12-17 | Lin Elizabeth Yeu | Chief Medical Officer | S 公開市場賣出 | 2.1K | 79.50 | 165K | 21.9K | SEC |
| 2025-12-15 | 01-14 | Goodrich Katherine | Director | M 選擇權執行 | 2.2K | – | – | 2.2K | SEC |
| 2025-12-15 | 12-17 | LINK WILLIAM J PHD | Director | S 公開市場賣出(10b5-1) | 6.3K | 81.75 | 516K | 130K | SEC |
| 2025-12-15 | 12-17 | LINK WILLIAM J PHD | Director | S 公開市場賣出(10b5-1) | 5.7K | 80.71 | 458K | 4.8K | SEC |
| 2025-12-15 | 12-17 | LINK WILLIAM J PHD | Director | S 公開市場賣出(10b5-1) | 5.0K | 80.80 | 408K | 136K | SEC |
| 2025-12-15 | 12-17 | Lin Elizabeth Yeu | Chief Medical Officer | M 選擇權執行 | 6.8K | – | – | 24.0K | SEC |
| 2025-12-15 | 12-17 | LINK WILLIAM J PHD | Director | S 公開市場賣出(10b5-1) | 4.8K | 81.50 | 388K | 0 | SEC |
| 2025-12-15 | 12-17 | LINK WILLIAM J PHD | Director | S 公開市場賣出(10b5-1) | 1.1K | 82.39 | 95K | 129K | SEC |
| 2025-12-04 | 12-08 | Azamian Bobak R. | President/CEO and Board Chair | G 贈與 | 51.9K | – | – | 1.8K | SEC |
| 2025-09-24 | 09-26 | Azamian Bobak R. | President/CEO and Board Chair | S 公開市場賣出(10b5-1) | 6.0K | 55.37 | 332K | 812K | SEC |
| 2025-09-16 | 09-18 | LINK WILLIAM J PHD | Director | G 贈與 | 2.0K | – | – | 141K | SEC |
| 2025-09-15 | 09-16 | Morrison Scott W | Director | M 選擇權執行 | 1.3K | – | – | 4.7K | SEC |
| 2025-09-08 | 09-10 | LINK WILLIAM J PHD | Director | S 公開市場賣出 | 27.1K | 57.00 | 1.5M | 143K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 3.9M | 243M | 新進 | 新進 |
| Deep Track Capital, LP | 3.7M | 231M | 新進 | 新進 |
| RTW INVESTMENTS, LP | 3.4M | 211M | 新進 | 新進 |
| Jupiter Topco LLC | 2.8M | 177M | 新進 | 新進 |
| Paradigm Biocapital Advisors LP | 2.8M | 175M | 新進 | 新進 |
| Assenagon Asset Management S.A. | 1.9M | 119M | 新進 | 新進 |
| MORGAN STANLEY | 1.8M | 115M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | 113M | 新進 | 新進 |
| JENNISON ASSOCIATES LLC | 1.7M | 105M | 新進 | 新進 |
| TANG CAPITAL MANAGEMENT LLC | 1.6M | 98.7M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 1.4M | 89.8M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 1.2M | 75.1M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | 69.6M | 新進 | 新進 |
| STATE STREET CORP | 1.1M | 67.5M | 新進 | 新進 |
| Vestal Point Capital, LP | 1.1M | 66.1M | 新進 | 新進 |
| Invesco Ltd. | 786K | 49.5M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 743K | 46.7M | 新進 | 新進 |
| Frazier Life Sciences Management, L.P. | 729K | 45.9M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 711K | 44.7M | 新進 | 新進 |
| FMR LLC | 673K | 42.4M | 新進 | 新進 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 607K | 38.2M | 新進 | 新進 |
| Clearbridge Investments, LLC | 549K | 34.6M | 新進 | 新進 |
| TORONTO DOMINION BANK | 510K | 32.1M | 新進 | 新進 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 427K | 26.9M | 新進 | 新進 |
| NORTHERN TRUST CORP | 387K | 24.3M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 257 +4 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 257 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 48.3M · 100.0% |
| 合計季末市值 | 3.0B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 6.0M |
|---|---|
| 與上期比 | +0.2% |
| 佔流通股數 | 13.70% |
| 日均成交量 | 613K |
| 回補天數 | 9.8 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 6.0M | +0.2% | 13.70% | 613K | 9.8 |
| 2026-08-14 | 6.0M | -0.3% | 13.67% | 801K | 7.5 |
| 2026-07-31 | 6.0M | +4.0% | 13.71% | 914K | 6.6 |
| 2026-07-15 | 5.8M | -1.8% | 13.18% | 1.8M | 3.2 |
| 2026-06-30 | 5.9M | +18.3% | 13.42% | 943K | 6.2 |
| 2026-06-15 | 5.0M | -2.9% | 11.35% | 559K | 8.9 |
| 2026-05-29 | 5.1M | +4.5% | 11.68% | 690K | 7.4 |
| 2026-05-15 | 4.9M | +1.8% | 11.18% | 856K | 5.7 |
| 2026-04-30 | 4.8M | +5.7% | 10.98% | 642K | 7.5 |
| 2026-04-15 | 4.6M | -0.4% | 10.39% | 344K | 13.2 |
| 2026-03-31 | 4.6M | -8.9% | 10.43% | 509K | 9.0 |
| 2026-03-13 | 5.0M | -5.7% | 11.44% | 495K | 10.1 |
| 2026-02-27 | 5.3M | -2.5% | 12.14% | 782K | 6.8 |
| 2026-02-13 | 5.5M | -6.1% | 12.44% | 556K | 9.8 |
| 2026-01-30 | 5.8M | +8.3% | 13.25% | 544K | 10.7 |
| 2026-01-15 | 5.4M | +17.9% | 12.23% | 524K | 10.2 |
| 2025-12-31 | 4.6M | -33.1% | 10.37% | 815K | 5.6 |
| 2025-12-15 | 6.8M | -4.3% | 15.51% | 454K | 15.0 |
| 2025-11-28 | 7.1M | -0.7% | 16.22% | 416K | 17.1 |
| 2025-11-14 | 7.2M | -1.5% | 16.33% | 491K | 14.6 |
| 2025-10-31 | 7.3M | +3.6% | 16.59% | 489K | 14.9 |
| 2025-10-15 | 7.0M | -3.0% | 16.01% | 693K | 10.1 |
| 2025-09-30 | 7.2M | -5.1% | 16.51% | 637K | 11.4 |
| 2025-09-15 | 7.6M | +10.2% | 17.40% | 833K | 9.2 |
| 2025-08-29 | 6.9M | -5.7% | 15.78% | 533K | 13.0 |
| 2025-08-15 | 7.3M | -9.8% | 16.73% | 803K | 9.1 |